Potential role of human growth hormone in melanoma growth promotion

Archives of Dermatology

Volumn 148, Issue 10, 2012, Pages 1179-1182

  Handler, Marc Z ^a   Ross, Andrew L ^a   Shiman, Michael I ^a   Elgart, George W ^a   Grichnik, James M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CASE REPORT; CLINICAL FEATURE; DRUG CARCINOGENICITY; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; MALE; MEDICAL HISTORY; MELANOMA SKIN CANCER; PAPULE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CARCINOGENESIS;

AGING; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MELANOMA; MIDDLE AGED; SELF MEDICATION; SKIN NEOPLASMS;

EID: 84867639329     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.2149     Document Type: Article

References (26)

1. Savine R, Sönksen P. Growth hormone: hormone replacement for the somatopause? Horm Res. 2000;53(suppl 3):37-41.
2. Blackman MR, Sorkin JD, Münzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002;288(18):2282-2292. (Pubitemid 35291758)
3. Perry JK, Emerald BS, Mertani HC, Lobie PE. The oncogenic potential of growth hormone. Growth Horm IGF Res. 2006;16(5-6):277-289. (Pubitemid 44793716)
4. Anderson NG. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J. 1992;284(pt 3):649-652.
5. Argetsinger LS, Campbell GS, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993;74(2):237-244. (Pubitemid 23221700)
6. Molhoek KR, Shada AL, Smolkin M, et al. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res. 2011;21(4):274-284.
7. Capoluongo E. Insulin-like growth factor system and sporadic malignant melanoma. Am J Pathol. 2011;178(1):26-31.
8. Yajima I, Kumasaka MY, Thang ND, et al. RAS/RAF/MEK/ERK and PI3K/PTEN/AKT signaling in malignant melanoma progression and therapy. Dermatol Res Pract. 2012;2012:354191.
9. Caldarola G, Battista C, Pellicano R. Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. Clin Ther. 2010;32(1):57-59.
10. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol. 2009;20(2):358-364.
11. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84(4):1155-1228. (Pubitemid 39287950)
12. Bourguignon JP, Piérard GE, Ernould C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet. 1993;341(8859):1505-1506. (Pubitemid 23168645)
13. Piérard GE, Piérard-Franchimont C, Nikkels A, Nikkels-Tassoudji N, Arrese JE, Bourguignon JP. Naevocyte triggering by recombinant human growth hormone. J Pathol. 1996;180(1):74-79. (Pubitemid 26348895)
14. Bozzola E, Giacchero R, Barberi S, Borroni G. Sutton's nevus and growth hormone therapy. Minerva Pediatr. 2004;56(3):349-351. (Pubitemid 38993550)
15. Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol. 1997;137(4):545-548. (Pubitemid 27469504)
16. Wyatt D. Melanocytic nevi in children treated with growth hormone. Pediatrics. 1999;104(4, pt 2):1045-1050.
17. Lincoln DT, Sinowatz F, Kölle S, Takahashi H, Parsons P, Waters M. Upregulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res. 1999;19(3A):1919-1931. (Pubitemid 29392758)
18. Fleming MG, Howe SF, Graf LH Jr. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol. 1994;16(4):383-391. (Pubitemid 24284344)
19. Tavakkol A, Elder JT, Griffiths CE, et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol. 1992;99(3):343-349.
20. Chatelain P, Naville D, Avallet O, et al. Paracrine and autocrine regulation of insulinlike growth factor I. Acta Paediatr Scand Suppl. 1991;372:92-96.
21. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowsk H. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer. 1987;40(5):687-690. (Pubitemid 18003861)
22. Satyamoorthy K, Li G, Vaidya B, Kalabis J, Herlyn M. Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Differ. 2002;13(2):87-93. (Pubitemid 34205516)
23. Kanter-Lewensohn L, Dricu A, Girnita L, Wejde J, Larsson O. Expression of insulinlike growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins. Growth Factors. 2000;17(3):193-202. (Pubitemid 30103478)
24. Ginarte M, García-Caballero T, Fernández-Redondo V, Beiras A, Toribio J. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities. J Cutan Pathol. 2000;27(6):276-282. (Pubitemid 30389567)
25. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A. Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med. 2000; 136(6):476-481.
26. Chatzistamou I, Volakaki AA, Schally AV, Kiaris H, Kittas C. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas. Regul Pept. 2008;147(1-3):33-36.